Genprex

Monthly Archives: July 2017

Genprex Files Registration Statement For Proposed Initial Public Offering

AUSTIN, TX, July 21, 2017 – Genprex, Inc. a clinical stage biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined….

Read More